STOCK TITAN

Omnicell to Present at the J.P. Morgan 39th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Omnicell (Nasdaq:OMCL) announced its participation in upcoming investor conferences. Randall Lipps, Chairman and CEO, and Peter Kuipers, CFO, will present at the J.P. Morgan 39th Annual Healthcare Conference on January 13, 2021, at 2:00 PM ET. Live and archived webcasts of the presentation will be accessible on the Omnicell website. Since its inception in 1992, Omnicell has focused on transforming pharmacy care delivery, with over 7,000 facilities worldwide utilizing its solutions to enhance efficiency and patient safety.

Positive
  • None.
Negative
  • None.

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences:

  • Randall Lipps, Omnicell Chairman, President, Chief Executive Officer, and Founder; and Peter Kuipers, Omnicell Executive Vice President, Chief Financial Officer, will present at the J.P. Morgan 39th Annual Healthcare Conference on Wednesday, January 13, 2021 at 2:00pm ET.

Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/communications/events-presentations

About Omnicell

Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 7,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. To learn more, visit www.omnicell.com.

OMCL-E

FAQ

What conference will Omnicell participate in on January 13, 2021?

Omnicell will present at the J.P. Morgan 39th Annual Healthcare Conference.

Who are the presenters for Omnicell at the upcoming conference?

Randall Lipps, Chairman and CEO, and Peter Kuipers, CFO, will present.

Where can I watch the Omnicell presentation?

The presentation will be available live and archived on the Omnicell website.

What is the focus of Omnicell's solutions?

Omnicell focuses on medication management and adherence tools for healthcare systems and pharmacies.

When is the J.P. Morgan 39th Annual Healthcare Conference scheduled?

It is scheduled for January 13, 2021, at 2:00 PM ET.

Omnicell Inc

NASDAQ:OMCL

OMCL Rankings

OMCL Latest News

OMCL Stock Data

2.08B
45.50M
1.56%
100.97%
3.59%
Health Information Services
Electronic Computers
Link
United States of America
FORT WORTH